Bendamustine/Rituximab Followed by High-dose Cytarabine/Rituximab Regimen

Preferred Label : Bendamustine/Rituximab Followed by High-dose Cytarabine/Rituximab Regimen;

NCIt synonyms : Bendamustine/Rituximab Followed by High-dose Cytarabine/Rituximab; Bendamustine-Rituximab Followed by High-dose Cytarabine-Rituximab; Bendamustine/Rituxan Followed by HiDAC/Rituxan;

NCIt definition : A regimen consisting of bendamustine and rituximab followed by high-dose cytarabine and rituximab that can be used for the treatment of mantle cell lymphoma (MCL).;

Détails

Origin ID

C210784;

chemotherapy_regimen_has_component
- Bendamustine [NCIt concept]
- Cytarabine [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients